Table: Sapporo Clinical Lab - 6-MTH group results

Sapporo Clinical Laboratory

08/11/2024 06:37

Nov 8 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2024        Sep 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             10.00               9.86             19.80    
                 (+1.4 pct)          (-1.0 pct)       (+0.6 pct)  
  Operating        337 mln             291 mln          500 mln   
                 (+16.0 pct)         (-40.9 pct)      (-6.4 pct)  
  Recurring        343 mln             296 mln          493 mln   
                 (+15.8 pct)         (-49.7 pct)      (-4.2 pct)  
  Net              222 mln             226 mln          320 mln   
                 (-1.7 pct)          (-12.4 pct)      (-15.8 pct) 
  EPS             70.87 yen           67.94 yen       102.36 yen  
  Ann Div                             23.00 yen        23.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             23.00 yen        23.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T